Gherardo Finocchiaro, Joseph Westaby, Elijah R Behr, Michael Papadakis, Sanjay Sharma, Mary N Sheppard. JAMA Cardiology. 2022 Mar 1. Read the paper here This case
Sabiha Gati, Sanjay Sharma. Heart (British Cardiac society). 2022 Feb 23. Read the paper here Hypertrophic cardiomyopathy (HCM) is the most frequently cited cause of
Dhutia H, Malhotra A, Finnochiaro G, Parpia S, Bhatia R, D’Silva A, Gati S, Mellor G, Narain R, Chandra N, Behr E, Tome M, Papadakis M, Sharma S. EP Europace, February 2021 (Read the abstract of this paper here).
Webinar Recording: Guidance for ‘Safe Exercise’ in the COVID-era & How to prepare for a return to sport https://www.youtube.com/watch?v=lWQdydy-B-k Agenda Introductions – Dr Steven CoxExercise in the COVID-19 era; Facts and fiction – Professor Sanjay SharmaGoing back to exercise; A roadmap to re-training – Professor Mathew WilsonCardiac evaluation prior to returning to sport; One size fits
Basu J Malhotra A Papadakis M Exercise and hypertrophic cardiomyopathy: Two incompatible entities? Clinical Cardiology, February 2020 {Paper} A greater understanding of the pathogenic mechanisms underpinning hypertrophic cardiomyopathy (HCM) has translated to improved medical care and better survival of affected individuals. Historically these patients were considered to be at high risk of sudden cardiac death (SCD)
Gati S, Malhotra A, Sharma S Exercise recommendations in patients with valvular disease BMJ Heart, January 2019 {Abstract} Valvular heart disease affects approximately 3% of young individuals, many of whom aspire to partake in competitive sport or high intensity recreational exercise. Although reports on the natural history of valvular heart disease in athletes are sparse, there
Diagnostic Yield of Genetic Testing in Young Athletes with T-Wave Inversion Sheikh N et al., Diagnostic Yield of Genetic Testing in Young Athletes With T-Wave Inversion. Circulation 2018;May 15 https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.118.034208 Regular intensive exercise is associated with a number of changes in the heart which include enlargement of the chambers, thickening (hypertrophy) of the muscle, and slowing
Miles C, Finocchiaro G, Papadakis M, Gray B, Westaby J, Ensam B, Basu J, Parry-Williams G, Papatheodorou E, Paterson C, Malhotra A, Robertus JL, Ware JS, Cook SA, Asimaki A, Witney A, Chis Ster I, Tome M, Sharma S, Behr ER, Sheppard MN Sudden death and left ventricular in arrhythmogenic cardiomyopathy American Heart Association Journal, January
Gherardo Finocchiaro, MD, Elijah R. Behr, MA, MBBS, Gaia Tanzarella, MD, Michael Papadakis, MBBS, MD, Aneil Malhotra, BSC, MBCHB, PHD, Harshil Dhutia, BSC, MBBS, Chris Miles, MBBS, Igor Diemberger, MD, PHD, Sanjay Sharma, BSC, MBCHB, MD, Mary N. Sheppard, MBBCH, BAO, BSC, MDc This study sought to describe the clinical and pathological features of anomalous origin
How did you conduct your study? This study sought to investigate the incidence and causes of sudden cardiac death in adolescent football players in the UK. The English Football Association cardiac screening programme enabled us to study a well-defined population of over 11,000 scholar footballers in a systematic way. The study itself was conducted across three